Dr. Scheherazade Traghis Le, MD

Dr. Le practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Le's NPI, 1689857971, was assigned on December 11, 2007. Dr. Le graduated from UCSF School of Medicine in 2006. Dr. Le's California license number on file is A101971.

Dr. Le's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Le's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Le is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Le to 1 more hospital and 1 medical group, each named with a free account. Dr. Le's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Le practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Le's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Le is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Le has a license on file in California.

Dmand AI lists epilepsy, migraine and chronic headache and seizures among the conditions Dr. Le treats.

CMS data shows 1,314 Medicare services from Dr. Le across 11 procedure codes in 2024, for 216 Medicare patients. Medicare paid $66,267 for them.

CMS counts 216 Medicare patients who saw Dr. Le in 2024. The largest group is 65 to 74, with 70 patients. 69% of them have high cholesterol, and 67% have high blood pressure. 44% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Le's median patient age at 41, with 54% women.

In 2024, Dr. Le wrote 1,264 Medicare Part D claims for 118 patients. 87% of them were for generic drugs. CMS names the drug for 1,151 of them, across 26 drugs with 11 or more claims each, at $642,885 in total drug cost. In 2023, CMS named 998 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Le for performance year 2024, reported as part of a group. Dr. Le accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Le as offering telehealth.

Dmand AI links 44 papers to Dr. Le, published from 2009 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Drug Resistant Epilepsy, Epilepsy and Intraoperative Neurophysiological Monitoring. Dr. Le has published most often in Epilepsy Behav. Dr. Le's most frequent co-authors are Leslie Hui-Lin Lee, MD, Robert Louis Dodd, MD, PhD and Leslie Lee, MD.

Dmand AI links Dr. Le to 1 clinical trial. Conditions studied include Seizures and Epilepsy.

CMS Open Payments shows 2 general payments to Dr. Le from 1 drug or device company in 2016. Food and beverage make up the largest share, 90% of the total. Neuropace, Inc. paid the most, $139.

Dmand AI lists 1 award for Dr. Le, most recently CMS Stage 1 EHR in 2013.

Dr. Le graduated from UCSF School of Medicine in 2006.

Dr. Le is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.